A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis

Abstract Background Glioma is sensitive to microtubule-targeting agents (MTAs), but most MTAs do not cross the blood brain barrier (BBB). To address this limitation, we developed the new chemical entity, ST-401, a brain-penetrant MTA. Methods Synthesis of ST-401. Measures of MT assembly and dynamics. Cell proliferation and viability of patient-derived (PD) glioma in culture. Measure of tumor microtube (TM) parameters using immunofluorescence analysis and machine learning-based workflow. Pharmacokinetics (PK) and experimental toxicity in mice. In vivo antitumor activity in the RCAS/tv-a PDGFB-driven glioma (PDGFB-glioma) mouse model. Results We discovered that ST-401 disrupts microtubule (MT) function through gentle and reverisible reduction in MT assembly that triggers mitotic delay and cell death in interphase. ST-401 inhibits the formation of TMs, MT-rich structures that connect glioma to a network that promotes resistance to DNA damage. PK analysis of ST-401 in mice shows brain penetration reaching antitumor concentrations, and in vivo testing of ST-401 in a xenograft flank tumor mouse model demonstrates significant antitumor activity and no over toxicity in mice. In the PDGFB-glioma mouse model, ST-401 enhances the therapeutic efficacies of temozolomide (TMZ) and radiation therapy (RT). Conclusion Our study identifies hallmarks of glioma tumorigenesis that are sensitive to MTAs and reports ST-401 as a promising chemical scaffold to develop brain-penetrant MTAs.

[1]  Andrea Comba,et al.  Self-organization in brain tumors: How cell morphology and cell density influence glioma pattern formation , 2019, bioRxiv.

[2]  A. M. Houghton,et al.  Anti-PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma. , 2019, Neuro-oncology.

[3]  H. Monyer,et al.  Emerging intersections between neuroscience and glioma biology , 2019, Nature Neuroscience.

[4]  Fred A. Hamprecht,et al.  ilastik: interactive machine learning for (bio)image analysis , 2019, Nature Methods.

[5]  A. Recasens,et al.  Lower Tubulin Expression in Glioblastoma Stem Cells Attenuates Efficacy of Microtubule-Targeting Agents. , 2019, ACS pharmacology & translational science.

[6]  Sébastien Motsch,et al.  3131 ONCOSTREAMS: NOVEL DYNAMICS PATHOLOGICAL MULTICELLULAR STRUCTURES INVOLVED IN GLIOBLATOMA GROWTH AND INVASION , 2019, Journal of Clinical and Translational Science.

[7]  H. Fine,et al.  Modeling Patient-Derived Glioblastoma with Cerebral Organoids. , 2019, Cell reports.

[8]  Eric A. Horne,et al.  Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells. , 2018, European journal of medicinal chemistry.

[9]  M. Steinmetz,et al.  Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton. , 2018, Trends in cell biology.

[10]  L. Rice,et al.  Microtubule dynamics: an interplay of biochemistry and mechanics , 2018, Nature Reviews Molecular Cell Biology.

[11]  R. Rabadán,et al.  Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma , 2018, Genes & development.

[12]  G. Ha,et al.  Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism , 2017, OncoTargets and therapy.

[13]  Andrea Comba,et al.  CSIG-11. ONCOSTREAMS: NOVEL STRUCTURES THAT SPECIFY GLIOMAS’ SELF-ORGANIZATION, ARE ANATOMICALLY DISCRETE, FUNCTIONALLY UNIQUE, AND MOLECULARLY DISTINCT , 2017 .

[14]  W. Wick,et al.  Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas , 2017, Neuro-oncology.

[15]  S. Heiland,et al.  Tweety-Homolog 1 Drives Brain Colonization of Gliomas , 2017, The Journal of Neuroscience.

[16]  M. Castro,et al.  Microtubule targeting agents in glioma. , 2016, Translational cancer research.

[17]  D. Liggitt,et al.  ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme , 2016, Molecular Cancer Therapeutics.

[18]  J. Sarkaria,et al.  Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma. , 2016, Neuro-oncology.

[19]  O. Garaschuk,et al.  Brain tumour cells interconnect to a functional and resistant network , 2015, Nature.

[20]  J. Lemée,et al.  Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone. , 2015, Neuro-oncology.

[21]  J. Miller,et al.  Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function. , 2014, Bioorganic & medicinal chemistry.

[22]  Patrick J. Paddison,et al.  Molecular Pathways: Regulation and Targeting of Kinetochore–Microtubule Attachment in Cancer , 2014, Clinical Cancer Research.

[23]  Linda Wordeman,et al.  Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells , 2014, Nature Cell Biology.

[24]  B. Ross,et al.  Mathematical Modeling of PDGF-Driven Glioblastoma Reveals Optimized Radiation Dosing Schedules , 2014, Cell.

[25]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[26]  T. Lagerweij,et al.  Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs. , 2013, Journal of the National Cancer Institute.

[27]  S. Attia.  Molecular cytogenetic evaluation of the mechanism of genotoxic potential of amsacrine and nocodazole in mouse bone marrow cells , 2013, Journal of Applied Toxicology.

[28]  Y. Yonekawa,et al.  Patupilone (Epothilone B) for Recurrent Glioblastoma: Clinical Outcome and Translational Analysis of a Single-Institution Phase I/II Trial , 2012, Oncology.

[29]  Stephen Yip,et al.  Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. , 2012, Neuro-oncology.

[30]  Timothy J. Mitchison,et al.  The proliferation rate paradox in antimitotic chemotherapy , 2012, Molecular biology of the cell.

[31]  T. Fojo,et al.  Mitosis is not a key target of microtubule agents in patient tumors , 2011, Nature Reviews Clinical Oncology.

[32]  K. Jaqaman,et al.  Robust single particle tracking in live cell time-lapse sequences , 2008, Nature Methods.

[33]  P. Pandolfi,et al.  PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. , 2008, Genes & development.

[34]  H. Varmus,et al.  A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. , 1998, Genes & development.

[35]  M. Jordan,et al.  Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. , 1992, Journal of cell science.